MedPath

Effect of intracoronary injection of autologous stemm cells on left ventricular ejection fraction and volumes one year after an acute myocardial infarction. Efecto de la inyección intracoronaria de células madre obtenidas de sangre periférica sobre la fracción de eyección y los volúmenes del ventrículo izquierdo al año de haber padecido un infarto agudo de miocardio.

Conditions
The trial evaluates the effect on left ventricular function recovery of the intracoronary injection of mononuclear white cells obtained from peripheral blood in the week after an acute myocardial infaction.
Registration Number
EUCTR2006-001772-20-ES
Lead Sponsor
Clinica Rotger
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
60
Inclusion Criteria

>18 and <75 years of age
STEMI: ST Elevation Myocardial Infarction
Reperfusion with PCI or lytics
Killip I-III
Damaged myocardial area > 2 segments

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Other concomitant cardiac diseases
Previous myocardial infarction
Killip IV
Women in childbearing age

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath